The clinical Phase I study conducted in the NEX-22 project with good results and focus on the evaluation with Novo Nordisk has provided a good starting point for 2025. Significant events during the fo ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.